General Practice Doctors in Manchester, NH Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Dr. Joseph John Lienert, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-6344

Dr. Vasilios P Lazos, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925

Dr. Graciela Silvia Sironich-kalkan, M.D. General Practice Medicare: May Accept Medicare Assignments Practice Location: 765 S Main St, Suite 103, Manchester, NH 03102 Phone: 603-625-1724    Fax: 603-625-1230

News Archive

Labcyte introduces pre-calibrated liquid class packages for use with its Echo acoustic dispensers

Today Labcyte introduced two pre-calibrated liquid class packages for use with its award-winning Echo® acoustic dispensers and POD™ 810 plate assemblers, which move liquids with sound. This expanded capability will allow its high throughput screening customers to not only transfer compounds in DMSO, but enables the transfer of a wide range of liquids necessary to assemble miniaturized assays for biochemical and cell-based screening.

Blood cancer patients show widely variable response to COVID-19 vaccines

Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines-in some cases, no detectable response-pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study that will be published in Cancer Cell this week.

CLSI's document provides revised guidelines for screening cystic fibrosis

Clinical and Laboratory Standards Institute (CLSI) recently published Sweat Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline—Third Edition (C34-A3). This document addresses appropriate methods of collection and analysis, quality control, and the evaluation and reporting of sweat test results for the diagnosis of cystic fibrosis.

SARS-CoV-2 beta variant elicits variant specific and cross-reactive antibodies

One recent study assessed the serum of Beta variant infected patients to determine whether major non-VOC antibodies could neutralize this virus.

Micronics receives FDA marketing clearance for ABORhCard

Micronics, Inc., a medical device development company, today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its ABORhCard, a qualitative in vitro test that provides a simultaneous determination of an individual's ABO blood group and Rh factor status. It is not for use for blood bank processing of blood products, for determining RHD status for the purpose of administration of Rh immunoglobulin, or for screening purposes prior to transfusion.

Read more Medical News

› Verified 1 days ago